Fluocortin
Chemical compound
- D07AB04 (WHO)
- 2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-Fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid
- 33124-50-4
Y
- 22875828
- 18865233
- 03837V0H1Y
- D07972 Y
- DTXSID30186785
- Interactive image
- C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@H]1C(=O)C(=O)O)C)O)C)F
InChI
- InChI=1S/C22H27FO5/c1-10-6-13-12-8-15(23)14-7-11(24)4-5-21(14,2)18(12)16(25)9-22(13,3)17(10)19(26)20(27)28/h4-5,7,10,12-13,15-18,25H,6,8-9H2,1-3H3,(H,27,28)/t10-,12+,13+,15+,16+,17-,18-,21+,22+/m1/s1
- Key:PUWHHWCHAVXSIG-NCLPIGKXSA-N
Fluocortin is a corticosteroid. It is similar to fluocortolone, but with one more keto group.[1]
References
- ^ Täuber U, Haack D, Nieuweboer B, Kloss G, Vecsei P, Wendt H (January 1984). "The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 22 (1): 48–55. PMID 6698661.
- v
- t
- e
| Natural | |
|---|---|
| Synthetic |
|
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
